Clinical Trial Update: Polidocanol Sclerotherapy of Pharynges for Obstructive Sleep Apnea (OSA) and Snoring Subjects(SS) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial update evaluating polidocanol sclerotherapy of the pharynx for treating obstructive sleep apnea. The sponsor is Liaoyang Centra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Drugs mentioned

• polidocanol (polidocanol)

Snippet

Sponsor: Liaoyang Central Hospital | Conditions: Apnea, Snoring | Phase 1, Phase 2 | Status: UNKNOWN